AACR 2026 年会

🚨 #ESMO26 Lung Cancer: Top Ten by @OncoAlert 🫁 The abstracts our faculty picked as must-know from Madrid 👇 1️⃣ DeLLphi-305 (LBA3): tarlatamab + durvalumab, 1L maintenance in ES-SCLC 2️⃣ Krascendo 1 (LBA5): divarasib vs sotorasib/adagrasib in KRAS G12C NSCLC 3️⃣ SAFFRON (LBA6): osimertinib + savolitinib in EGFRm MET+ NSCLC post-osimertinib 4️⃣ OptiTROP-Lung04 (LBA67): final OS, sac-TMT vs chemo after EGFR-TKI 5️⃣ OptiTROP-Lung06 (LBA66): sac-TMT + pembro, 1L PD-L1-negative non-squamous NSCLC 6️⃣ PERSEE (2614O): pembro ± chemo, 1L PD-L1 ≥50% 7️⃣ SANOVO (LBA69): savolitinib + osimertinib, 1L EGFRm MET-overexpressed NSCLC 8️⃣ IFCT-2103 DIAL (2618RO): continue pembro vs observation at 6 months 9️⃣ PANKU-Lung01 (LBA71): iza-bren after third-generation EGFR TKI 🔟 SARON (2613O): consolidation radiotherapy in oligometastatic NSCLC #lcsm #OncoAlert #MedTwitter Pinging our OncoAlert Lung Cancer Faculty @christine_lovly, @GlopesMd, @DrSanjayPopat, @StephenVLiu, @jillfeldman4, @UOzkerim, @DrMirallas, @MartinReck2 , @bmassutis @UmbertoMalapel1 , @CharuAggarwalMD @peters_solange, @HenningWillers, @HHorinouchi, @BRicciutiMD, @PercyLeeMD, @bensolomon1, @Latinamd, @DrJNaidoo, @barlesi, @VanitaNoronha, @ChristianRolfo @Tony_Calles @s_couraud @marinagarassino @g_mountzios @BairdAM @barlesi @JFreemanDaily @Piuchagarrido @LeciaSequist @bensolomon1 @VanitaNoronha +@alexdrilon @JordiRemon @caliraf @JulienMazieres @TerriConneran

Delighted to join Dr Yi-Chen Zhang, Dr Calvo de Juan and Prof Yi-Long Wu in discussing the role of local therapy in non-small cell lung cancer at #ESMO26 in #Madrid this afternoon. Superb case discussion and fascinating insights into novel approaches such as the role of ctDNA In selection and monitoring of patients. @myESMO @CancerInstIRE @tcddublin @TrinityMed1

It was an amazing surprise! Gracias Totales! #ESMO26

Delighted to join Dr Yi-Chen Zhang, Dr Calvo de Juan and Prof Yi-Long Wu in discussing the role of local therapy in non-small cell lung cancer at #ESMO26 in #Madrid this afternoon. Superb case discussion and fascinating insights into novel approaches such as the role of ctDNA In selection and monitoring of patients. @myESMO @CancerInstIRE @tcddublin @TrinityMed1

Delighted to join Dr Yi-Chen Zhang, Dr Calvo de Juan and Prof Yi-Long Wu in discussing the role of local therapy in non-small cell lung cancer at #ESMO26 in #Madrid this afternoon. Superb case discussion and fascinating insights into novel approaches such as the role of ctDNA In selection and monitoring of patients. @myESMO @CancerInstIRE @tcddublin @TrinityMed1

Important implications for lung cancer, too. We’re behind breast cancer in understanding optimal ADC sequencing, but emerging data raise an important concern: switching targets may not overcome resistance when the payload remains the same... #ESMO26